U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement

Aug.28.2025
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
The U.S. Bankruptcy Court in New York has approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., granting legal effect in the U.S. to its participation in a CA$32.5 billion (US$23.6 billion) tobacco litigation settlement. The case is considered one of the largest corporate restructurings in Canadian history and also involves Japan Tobacco International (JTI), Philip Morris International (PMI), and British American Tobacco (BAT).

Key Points

 

  • Court Ruling: U.S. Bankruptcy Court approved and recognized Imperial Tobacco Canada’s restructuring plan under Chapter 15 of the U.S. Bankruptcy Code.
  • Settlement Amount: The three tobacco companies will pay CA$32.5 billion (US$23.6 billion), including CA$12.5 billion (US$9.1 billion) in upfront cash, with the remainder from net after-tax income over the next 20 years.
  • Background: In 2019, Imperial Tobacco Canada, JTI-Macdonald, and Rothman Benson & Hedges faced claims totaling CA$1 trillion and entered insolvency proceedings.
  • International Dimension: While Imperial Tobacco Canada does not sell products overseas, its supply chain and inventory involve the U.S., along with legacy pension liabilities.

 


 

2Firsts, August 28, 2025 —— According to Law360 on August 26, U.S. Bankruptcy Judge John P. Mastando III of the Southern District of New York formally approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., thereby confirming the legal effect in the U.S. of its participation in the CA$32.5 billion (US$23.6 billion) tobacco litigation settlement.

 

The agreement is regarded as one of the largest restructurings in Canadian history. Imperial Tobacco Canada’s U.S. counsel, Jennifer Feldsher, stated in court: “This is one of the largest, if not the largest, restructurings in Canadian history.”

 

Imperial Tobacco Canada is one of the three largest tobacco distributors in Canada and a subsidiary of British American Tobacco (BAT). In 2019, the company, along with JTI-Macdonald Corp. and Rothman, Benson & Hedges Inc., entered Canadian insolvency proceedings in response to CA$1 trillion (US$725.6 billion) in health-related tobacco claims.

 

  • JTI-Macdonald Corp. is the Canadian subsidiary of Japan Tobacco International (JTI).
  • Rothmans, Benson & Hedges Inc. is the Canadian arm of Philip Morris International (PMI).
  • Imperial Tobacco Canada Ltd. is the Canadian subsidiary of British American Tobacco (BAT).

 

After years of mediation—delayed significantly by the COVID-19 pandemic—the parties reached a settlement in 2024. Under the terms, the three companies will pay into a CA$32.5 billion (US$23.6 billion) fund to compensate class action claimants and reimburse Canadian provincial governments for healthcare costs related to tobacco use.

 

The agreement stipulates that nearly CA$12.5 billion (US$9.1 billion) will be paid upfront in cash, while the remainder will be drawn from the majority of the companies’ net after-tax income over the next 20 years.

 

Feldsher noted that this settlement is the largest of its kind since the 1998 Master Settlement Agreement in the U.S., when American tobacco companies agreed to pay more than US$200 billion.

 

Imperial Tobacco Canada filed its restructuring plan in October 2024, which was approved by a Canadian court in March 2025. Although Imperial Tobacco Canada does not sell tobacco outside of Canada, its supply chain passes through the U.S., where it also stores inventory. The company also resolved legacy pension liabilities stemming from acquisitions of U.S. companies.

 

Subsequently, Imperial Tobacco Canada sought U.S. recognition of the plan. Judge Mastando granted the request, recognized the Canadian court-appointed plan administrator, and issued an order barring unauthorized solicitation of claims in the case.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
One Nation Proposes 50% Tobacco Excise Cut as Australia’s Illicit Market Expands
One Nation Proposes 50% Tobacco Excise Cut as Australia’s Illicit Market Expands
Australian One Nation leader Pauline Hanson has proposed cutting tobacco excise by 50% and freezing indexation until June 30, 2028, in a bid to lower legal cigarette prices and reduce the price advantage of the illicit tobacco market.
Jun.18
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA’s proposed rule requiring foreign tobacco manufacturers to register establishments and list products is more than routine paperwork, Keller and Heckman LLP partner Azim Chowdhury told 2Firsts. He said it could strengthen FDA’s import enforcement, inspections and market surveillance. Chinese e-cigarette OEM/ODM manufacturers, specification developers, brand owners and component suppliers may need to review their roles, product data and U.S. market authorization status.
Special Report
Jun.29
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
According to The Wall Street Journal, people familiar with the matter said President Trump has signed off on a plan to fire FDA Commissioner Marty Makary, though the plan is not yet final and could change. The report said Makary’s tenure has included clashes over vaping, abortion and drug policy, and that some senior administration officials view him as struggling to manage the agency.
May.09 by 2FIRSTS.ai
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
The Philippine Department of Health said it is pushing for a total ban on vape products. If a full ban is not feasible, DOH officer-in-charge Director Dr. Dominic Maddumba said vape products should at least be limited to plain tobacco flavors to reduce their appeal to minors.
May.06 by 2FIRSTS.ai